Paradigm Biopharmaceuticals halted as it reviews response from Food & Drug Administration

Retrieved on: 2021-07-30 02:48:45

Tags for this article:

Click the tags to see associated articles and topics

Paradigm Biopharmaceuticals halted as it reviews response from Food & Drug Administration. View article details on hiswai:

Excerpt

Securities will remain halted until Tuesday, August 3, 2021, or when an announcement is released to the market. Paradigm Biopharmaceuticals Ltd ...

Article found on: www.proactiveinvestors.com.au